| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Running a Business or Managing a Business? |
|
Digg It - Running a Business or Managing a Business?
Growth of a business requires people to work on and not simply in the business. It is a very small amount of directors that actually understand what they are me According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ant to do when they are a director. They must understand their duties and responsibilities for the business to be effective There is a school of thought that ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in believes the business should run the directors and not the other way round. An effective business requires people working in the business not just on it. The lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. majority of small businesses do not work - plain and simple. Over eighty percent of small businesses fail within the first three years. Most small businesses here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe are run by owner-managers who bear all the hallmarks of victims. They will complain about overheads, staff, etc. and their businesses will never achieve their p d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro otential because they are always working in the business and not on it.
The key to avoiding this state of affairs is the recognition that a business needs to b ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e run and managed –things need to be planned and designed, they just don’t happen.
It is essential for people to spend more time working on the business and no easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t in the business. This is the magic formula for enabling you to run the business and not have the business run you. So the question then begs should one be a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically director or manager? Many small business directors are given the title as a matter of course or because they happen to be sitting in the room at the time t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ he company is formed.
How many directors or board directors actually know the difference between managing and directing? The typical response is complaints ab ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi out the board and the responsibilities for the business, share options and so forth. It is almost as though many people put into these roles were meant to know ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the job by instinct once given the role. The bottom line is that there is no manual and many people make it up as they go along. To define further, manage dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rs look after day to day affairs and are glorified supervisors.
Directors, on the other hand, are responsible for all aspects of the business and its future di cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin rection. The role of the board is fundamental to the growth of the business. In recent years, the board’s duties have been clarified, with the four main a tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen reas of the board being: Strategic thought Formulation of policy Managing the managers Accountability There are some dilemmas arise from t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel he four roles, however.
The skills to move the business forward while keeping it under control must be demonstrated. The board must be alert to the short term ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust pressures while being kept informed of the broader trends and competition externally.
The board must retain an objective point of view and stand back from day y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products to day running whilst maintaining a sufficient knowledge of what is going on. Commercial needs of the business need to be balanced with the need to act respon . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de sibly to towards employees, its business partners and general society.
Without clarity of leadership, focus, vision and mission the business will suffer greatl elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip y.
One of the great challenges for the growing business is to appoint and run an effective board that leads the business – working on and not in, the business. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Nanotechnology - For All To Use, or Only For The Free (Read Wealthy)?
|